# Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity

> **NCT04361474** · PHASE3 · COMPLETED · sponsor: **Fondation Ophtalmologique Adolphe de Rothschild** · enrollment: 120 (actual)

## Conditions studied

- Budesonide
- Olfaction Disorders
- SARS-CoV-2
- Anosmia

## Interventions

- **DRUG:** Budesonide Nasal
- **OTHER:** Physiological serum

## Key facts

- **NCT ID:** NCT04361474
- **Lead sponsor:** Fondation Ophtalmologique Adolphe de Rothschild
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-18
- **Primary completion:** 2020-11-24
- **Final completion:** 2021-06-25
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2026-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04361474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04361474, "Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04361474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*